Tumorigenesis is often described as a result of accumulated mutations that lead to growth advantage and clonal expansion of mutated cells. There is evidence in the literature that cancer cells are influenced by the microenvironment. Our previous studies demonstrated that the mouse mammary gland is capable of redirecting mouse cells of non-mammary origins as well as Mouse Mammary Tumor Virus (MMTV)-neu transformed cells toward normal mammary epithelial cell fate during gland regeneration. Interestingly, the malignant phenotype of MMTV-neu transformed cells was suppressed during serial transplantation experiments. Here, we discuss our studies that demonstrated the potential of the regenerating mouse mammary gland to redirect cancer cells of different species into a functional tumor-free mammary epithelial cell progeny. Immunochemistry for human specific CD133, mitochondria, cytokeratins as well as milk proteins and FISH for human specific probe identified human epithelial cell progeny in ducts, lobules, and secretory acini. Fluorescent In Situ Hybridization (FISH) for human centromeric DNA and FACS analysis of propidium iodine staining excluded the possibility of mouse-human cell fusion. To our knowledge this is the first evidence that human cancer cells of embryonic or somatic origins respond to developmental signals generated by the mouse mammary gland microenvironment during gland regeneration in vivo.
References
[1]
Felsher, D.W. Cancer revoked: Oncogenes as therapeutic targets. Nat. Rev. Cancer 2003, 3, 375–380, doi:10.1038/nrc1070.
[2]
Vogelstein, B.; Kinzler, K.W. Cancer genes and the pathways they control. Nat. Med. 2004, 10, 789–799, doi:10.1038/nm1087.
[3]
Jain, M.; Arvanitis, C.; Chu, K.; Dewey, W.; Leonhardt, E.; Trinh, M.; Sundberg, C.D.; Bishop, J.M.; Felsher, D.W. Sustained loss of a neoplastic phenotype by brief inactivation of myc. Science 2002, 297, 102–104.
[4]
Hochedlinger, K.; Blelloch, R.; Brennan, C.; Yamada, Y.; Kim, M.; Chin, L.; Jaenisch, R. Reprogramming of a melanoma genome by nuclear transplantation. Genes Dev. 2004, 18, 1875–1885, doi:10.1101/gad.1213504.
[5]
McCullough, K.D.; Coleman, W.B.; Ricketts, S.L.; Wilson, J.W.; Smith, G.J.; Grisham, J.W. Plasticity of the neoplastic phenotype in vivo is regulated by epigenetic factors. Proc. Natl. Acad. Sci. USA 1998, 95, 15333–15338.
[6]
Stoker, A.W.; Hatier, C.; Bissell, M.J. The embryonic environment strongly attenuates v-src oncogenesis in mesenchymal and epithelial tissues, but not in endothelia. J. Cell. Biol. 1990, 111, 217–228, doi:10.1083/jcb.111.1.217.
[7]
Rous, P. A transmissible avian neoplasm. J. Exp. Med. 1979, 150, 738–753.
[8]
Rous, P. A transmissible avian neoplasm. (sarcoma of the common fowl.). J. Exp. Med. 1910, 12, 696–705, doi:10.1084/jem.12.5.696.
[9]
Stoker, A.W.; Hatier, C.; Bissell, M.J. The embryonic environment strongly attenuates v-scr oncogenesis in mesenchymal and epithelial tissues, but not in endothelia. J. Cell. Biol. 1990, 111, 217–228, doi:10.1083/jcb.111.1.217.
[10]
Illmensee, K.; Mintz, B. Totipotency and normal differentiation of single teratocarcinoma cells cloned by injection into blastocysts. Proc. Natl. Acad. Sci. USA 1976, 73, 549–553.
[11]
Gerschenson, M.; Graves, K.; Carson, S.D.; Wells, R.S.; Pierce, G.B. Regulation of melanoma by the embryonic skin. Proc. Natl. Acad. Sci. USA 1986, 83, 7307–7310.
[12]
Mintz, B.; Illmensee, K. Normal genetically mosaic mice produced from malignant teratocarcinoma cells. Proc. Natl. Acad. Sci. USA 1975, 72, 3585–3589.
[13]
McCullough, K.D.; Coleman, W.B.; Ricketts, S.L.; Wilson, J.W.; Smith, G.J.; Grisham, J.W. Plasticity of the neoplastic phenotype in vivo is regulated by epigenetic factors. Proc. Natl. Acad. Sci. USA 1998, 95, 15333–15338.
[14]
Brinster, R.L. The effect of cells transferred into the mouse blastocyst on subsequent development. J. Exp. Med. 1974, 140, 1049–1056, doi:10.1084/jem.140.4.1049.
[15]
Pierce, G.B.; Dixon, F.J., Jr. Testicular teratomas. Ii. Teratocarcinoma as an ascitic tumor. Cancer 1959, 12, 584–589, doi:10.1002/1097-0142(195905/06)12:3<584::AID-CNCR2820120317>3.0.CO;2-F.
[16]
Pierce, G.B. Jr.; Dixon, F.J., Jr.; Verney, E.L. Teratocarcinogenic and tissue-forming potentials of the cell types comprising neoplastic embryoid bodies. Lab. Invest. 1960, 9, 583–602.
[17]
Pierce, G.B., Jr.; Verney, E.L. An in vitro and in vivo study of differentiation in teratocarcinomas. Cancer 1961, 14, 1017–1029, doi:10.1002/1097-0142(196109/10)14:5<1017::AID-CNCR2820140516>3.0.CO;2-P.
[18]
Pierce, G.B.; Aguilar, D.; Hood, G.; Wells, R.S. Trophectoderm in control of murine embryonal carcinoma. Cancer Res. 1984, 44, 3987–3996.
[19]
Papaioannou, V.E.; McBurney, M.W.; Gardner, R.L.; Evans, M.J. Fate of teratocarcinoma cells injected into early mouse embryos. Nature 1975, 258, 70–73.
[20]
Pierce, G.B.; Pantazis, C.G.; Caldwell, J.E.; Wells, R.S. Specificity of the control of tumor formation by the blastocyst. Cancer Res. 1982, 42, 1082–1087.
[21]
Bussard, K.M.; Boulanger, C.A.; Booth, B.W.; Bruno, R.D.; Smith, G.H. Reprogramming human cancer cells in the mouse mammary gland. Cancer Res. 2010, 70, 6336–6343.
[22]
Boulanger, C.A.; Smith, G.H. Reprogramming cell fates in the mammary microenvironment. Cell Cycle 2009, 8, 1127–1132, doi:10.4161/cc.8.8.8189.
[23]
Boulanger, C.A.; Wagner, K.U.; Smith, G.H. Parity-induced mouse mammary epithelial cells are pluripotent, self-renewing and sensitive to tgf-beta1 expression. Oncogene 2005, 24, 552–560, doi:10.1038/sj.onc.1208185.
[24]
Bruno, R.D.; Boulanger, C.A.; Smith, G.H. Notch-induced mammary tumorigenesis does not involve the lobule-limited epithelial progenitor. Oncogene 2012, 31, 60–67, doi:10.1038/onc.2011.215.
[25]
Booth, B.W.; Mack, D.L.; Androutsellis-Theotokis, A.; McKay, R.D.; Boulanger, C.A.; Smith, G.H. The mammary microenvironment alters the differentiation repertoire of neural stem cells. Proc. Natl. Acad. Sci. USA 2008, 105, 14891–14896.
[26]
Boulanger, C.A.; Bruno, R.D.; Rosu-Myles, M.; Smith, G.H. The mouse mammary microenvironment redirects mesoderm-derived bone marrow cells to a mammary epithelial progenitor cell fate. Stem Cells Dev. 2012, 21, 948–954, doi:10.1089/scd.2011.0148.
[27]
Boulanger, C.A.; Mack, D.L.; Booth, B.W.; Smith, G.H. Interaction with the mammary microenvironment redirects spermatogenic cell fate in vivo. Proc. Natl. Acad. Sci. USA 2007, 104, 3871–3876.
[28]
Booth, B.W.; Boulanger, C.A.; Anderson, L.H.; Smith, G.H. The normal mammary microenvironment suppresses the tumorigenic phenotype of mouse mammary tumor virus-neu-transformed mammary tumor cells. Oncogene 2011, 30, 679–689.
[29]
Bussard, K.M.; Smith, G.H. Human breast cancer cells are redirected to mammary epithelial cells upon interaction with the regenerating mammary gland microenvironment in vivo. PLoS One 2012, 7, e49221, doi:10.1371/journal.pone.0049221.
[30]
Booth, B.W.; Boulanger, C.A.; Smith, G.H. Stem cells and the mammary microenvironment. Breast Dis. 2008, 29, 57–67.
[31]
Deome, K.B.; Faulkin, L.J., Jr.; Bern, H.A.; Blair, P.B. Development of mammary tumors from hyperplastic alveolar nodules transplanted into gland-free mammary fat pads of female c3h mice. Cancer Res. 1959, 19, 515–520.
[32]
Bruno, R.D.; Smith, G.H. Functional characterization of stem cell activity in the mouse mammary gland. Stem Cell. Rev. 2011, 7, 238–247, doi:10.1007/s12015-010-9191-9.
[33]
Daniel, C.W.; Deome, K.B. Growth of mouse mammary glands in vivo after monolayer culture. Science 1965, 149, 634–636.
[34]
Faulkin, L.J., Jr.; Deome, K.B. Regulation of growth and spacing of gland elements in the mammary fat pad of the c3h mouse. J. Natl Cancer Inst. 1960, 24, 953–969.
[35]
Brisken, C.; O'Malley, B. Hormone action in the mammary gland. Cold Spring Harb. Perspect Biol. 2010, 2, a003178, doi:10.1101/cshperspect.a003178.
[36]
Smith, G.H. Experimental mammary epithelial morphogenesis in an in vivo model: Evidence for distinct cellular progenitors of the ductal and lobular phenotype. Breast Cancer Res. Treat. 1996, 39, 21–31, doi:10.1007/BF01806075.
[37]
Chen, C.C.; Stairs, D.B.; Boxer, R.B.; Belka, G.K.; Horseman, N.D.; Alvarez, J.V.; Chodosh, L.A. Autocrine prolactin induced by the pten-akt pathway is required for lactation initiation and provides a direct link between the akt and stat5 pathways. Genes Dev. 2012, 26, 2154–2168, doi:10.1101/gad.197343.112.
[38]
Chen, E.H.; Grote, E.; Mohler, W.; Vignery, A. Cell-cell fusion. FEBS Lett. 2007, 581, 2181–2193, doi:10.1016/j.febslet.2007.03.033.
[39]
Vignery, A. Macrophage fusion: Are somatic and cancer cells possible partners? Med. Sci. (Paris) 2005, 21, 1070–1075, doi:10.1051/medsci/200521121070.
[40]
Azuma, H.; Paulk, N.; Ranade, A.; Dorrell, C.; Al-Dhalimy, M.; Ellis, E.; Strom, S.; Kay, M.A.; Finegold, M.; Grompe, M. Robust expansion of human hepatocytes in fah-/-/rag2-/-/il2rg-/- mice. Nat. Biotechnol. 2007, 25, 903–910, doi:10.1038/nbt1326.
[41]
Okamura, K.; Asahina, K.; Fujimori, H.; Ozeki, R.; Shimizu-Saito, K.; Tanaka, Y.; Teramoto, K.; Arii, S.; Takase, K.; Kataoka, M.; et al. Generation of hybrid hepatocytes by cell fusion from monkey embryoid body cells in the injured mouse liver. Histochem. Cell. Biol 2006, 125, 247–257, doi:10.1007/s00418-005-0065-1.
[42]
Pajcini, K.V.; Pomerantz, J.H.; Alkan, O.; Doyonnas, R.; Blau, H.M. Myoblasts and macrophages share molecular components that contribute to cell-cell fusion. J. Cell. Biol. 2008, 180, 1005–1019.
[43]
Kordon, E.C.; Smith, G.H. An entire functional mammary gland may comprise the progeny from a single cell. Development 1998, 125, 1921–1930.
[44]
Smith, G.H.; Gallahan, D.; Zwiebel, J.A.; Freeman, S.M.; Bassin, R.H.; Callahan, R. Long-term in vivo expression of genes introduced by retrovirus-mediated transfer into mammary epithelial cells. J. Virol. 1991, 65, 6365–6370.
[45]
Dalerba, P.; Kalisky, T.; Sahoo, D.; Rajendran, P.S.; Rothenberg, M.E.; Leyrat, A.A.; Sim, S.; Okamoto, J.; Johnston, D.M.; Qian, D.; et al. Single-cell dissection of transcriptional heterogeneity in human colon tumors. Nat. Biotechnol. 2011, 29, 1120–1127.
[46]
Fearon, E.R.; Hamilton, S.R.; Vogelstein, B. Clonal analysis of human colorectal tumors. Science 1987, 238, 193–197.
[47]
Fialkow, P.J. Clonal origin of human tumors. Annu. Rev. Med. 1979, 30, 135–143, doi:10.1146/annurev.me.30.020179.001031.
[48]
Reya, T.; Morrison, S.J.; Clarke, M.F.; Weissman, I.L. Stem cells, cancer, and cancer stem cells. Nature 2001, 414, 105–111.
[49]
Marx, J. Cancer research. Mutant stem cells may seed cancer. Science 2003, 301, 1308–1310, doi:10.1126/science.301.5638.1308.
[50]
Al-Hajj, M.; Wicha, M.S.; Benito-Hernandez, A.; Morrison, S.J.; Clarke, M.F. Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. USA 2003, 100, 3983–3988.
[51]
Louderbough, J.M.; Schroeder, J.A. Understanding the dual nature of cd44 in breast cancer progression. Mol. Cancer Res. 2011, 9, 1573–1586, doi:10.1158/1541-7786.MCR-11-0156.
[52]
Smith, G.H. Experimental mammary epithelial morphogenesis in an in vivo model: Evidence for distinct cellular progenitors of the ductal and lobular phenotype. Breast Cancer Res. Treat. 1996, 39, 21–31, doi:10.1007/BF01806075.
[53]
Boulanger, C.A.; Wagner, K.U.; Smith, G.H. Parity-induced mouse mammary epithelial cells are pluripotent, self-renewing and sensitive to tgf-beta1 expression. Oncogene 2005, 24, 552–560, doi:10.1038/sj.onc.1208185.
[54]
Wagner, K.U.; Boulanger, C.A.; Henry, M.D.; Sgagias, M.; Hennighausen, L.; Smith, G.H. An adjunct mammary epithelial cell population in parous females: Its role in functional adaptation and tissue renewal. Development 2002, 129, 1377–1386.
